Q&A

The Missing Link Between AI Innovation And Manufacturing Execution

Source: Siemens
Siemens-PHA-LS-Marketplace-Graphics-Increase-research-efficiency-and-flexibility_original (1)

AI is the new buzzword across just about every industry and pharma is no exception. For leaders considering how best to integrate AI, automation, and digital initiatives onto the pharma manufacturing floor, the primary obstacle is maintaining compliance and control. Due to the delicate nature of these processes, sponsors leveraging digital transformation initiatives must support their effort with robust governance, orchestration, and security efforts.

Though the task may seem daunting, manufacturers that choose to be strategic and deliberate about when and where AI is allowed to operate will rapidly see the benefits of this technology. Industrial AI can be applied to analyze data, identify complex patterns, and propose solutions, however, it is not meant to make uncontrolled changes or replace human SMEs. Download the full Q&A article to gain expert insight into how better governance and orchestration can ensure that traceability is continuous and human oversight is built into AI processes.

access the Q&A!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene